Company Profile

Hovione is a fully integrated CDMO offering from drug substance to drug product intermediate to drug product. With FDA inspected sites in Portugal, the U.S., Ireland and Macau, China, Hovione provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds, niche generic API products, and offers proprietary product development and licensing opportunities for drug products. Hovione stands behind an average of 4% of NDA approvals each year, and its DMFs and CEPs are referenced in dozens of ANDAs and marketing authorization that are approved each year.

Hovione is a company with a culture based on innovation, quality and delivery.